Thomas E. Darga

Medicine · Health Sciences

26h-index6.8kcitations62works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

PARP inhibition in cancer therapy(10), DNA Repair Mechanisms(8), Virus-based gene therapy research(8), Cancer, Hypoxia, and Metabolism(8), Cytokine Signaling Pathways and Interactions(8)

Publications62 total

Supplementary Table 2S from Progression of Barrett's Metaplasia to Adenocarcinoma Is Associated with the Suppression of the Transcriptional Programs of Epidermal Differentiation
2023Open Access
Data from Progression of Barrett's Metaplasia to Adenocarcinoma Is Associated with the Suppression of the Transcriptional Programs of Epidermal Differentiation
2023Open Access
Data from Progression of Barrett's Metaplasia to Adenocarcinoma Is Associated with the Suppression of the Transcriptional Programs of Epidermal Differentiation
2023Open Access
Supplementary Table 1S from Progression of Barrett's Metaplasia to Adenocarcinoma Is Associated with the Suppression of the Transcriptional Programs of Epidermal Differentiation
2023Open Access
Supplementary Methods, Figure Legends 1-6 from Poly(ADP-Ribose) Polymerase Inhibitor Induces Accelerated Senescence in Irradiated Breast Cancer Cells and Tumors
2023Open Access
Supplementary Figures 1-6 from Poly(ADP-Ribose) Polymerase Inhibitor Induces Accelerated Senescence in Irradiated Breast Cancer Cells and Tumors
2023Open Access
Supplementary Methods, Figure Legends 1-6 from Poly(ADP-Ribose) Polymerase Inhibitor Induces Accelerated Senescence in Irradiated Breast Cancer Cells and Tumors
2023Open Access
Supplementary Table 2S from Progression of Barrett's Metaplasia to Adenocarcinoma Is Associated with the Suppression of the Transcriptional Programs of Epidermal Differentiation
2023Open Access
Data from Poly(ADP-Ribose) Polymerase Inhibitor Induces Accelerated Senescence in Irradiated Breast Cancer Cells and Tumors
2023Open Access
Supplementary Table 1S from Progression of Barrett's Metaplasia to Adenocarcinoma Is Associated with the Suppression of the Transcriptional Programs of Epidermal Differentiation
2023Open Access
Data from Poly(ADP-Ribose) Polymerase Inhibitor Induces Accelerated Senescence in Irradiated Breast Cancer Cells and Tumors
2023Open Access
Supplementary Figures 1-6 from Poly(ADP-Ribose) Polymerase Inhibitor Induces Accelerated Senescence in Irradiated Breast Cancer Cells and Tumors
2023Open Access
Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs
Oncotarget·2016· 177 citedOpen Access
Histological and <i>in vivo</i> characterization of oligo- and poly- metastasis(es) derived from tail-vein injected MDA-MB-435-GFP lung derivative cell lines.
Figshare·2015Open Access
14q32-Encoded MicroRNAs Mediate Oligometastasis
International Journal of Radiation Oncology*Biology*Physics·2015Open Access
14q32-encoded microRNAs mediate an oligometastatic phenotype
Oncotarget·2015· 110 citedOpen Access
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Immunity·2014· 2.0k citedOpen Access
Abstract 5019: Irradiation and anti-B7-H1 provide synergistic treatment effects in murine cancer
Cancer Research·2014
RIG-1-Like Receptor LGP2 Protects Tumor Cells From Ionizing Radiation
International Journal of Radiation Oncology*Biology*Physics·2014
DNA Repair Pathway Gene Expression Score Correlates with Repair Proficiency and Tumor Sensitivity to Chemotherapy
Science Translational Medicine·2014· 96 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Ralph R. Weichselbaum(44), Nikolai N. Khodarev(30), Mitchell C. Posner(21), Helena J. Mauceri(19), Edwardine Labay(14), Elena V. Efimova(13), Michael A. Beckett(12), Sean P. Pitroda(11), Samuel Hellmän(10), Harold G. Sutton(9), Bernard Roizman(8), Sajid Khan(8), James O. Park(8), Steven J. Chmura(7), Daniel W. Golden(7), Stephen J. Kron(7), Hua Liang(6), Yves A. Lussier(6), Joseph K. Salama(6), Kerrington D. Smith(6)